2015 Guidance on cancer immunotherapy development in early-phase clinical studies

Guidance Development Review Committee, Working Group for Clinical Studies of Cancer Immunotherapy, Working Group for Effector Cell Therapy, Working Group for CMC/Non-clinical Studies, Working Group for Cancer Vaccines and Adjuvants, Working Group for Anti-immune Checkpoint Therapy and Comprehensive Cancer Immunotherapy, and Biostatistics Subcommittee

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of '2015 Guidance on cancer immunotherapy development in early-phase clinical studies'. Together they form a unique fingerprint.

Medicine & Life Sciences